Whitepaper

Much Ado About Nothing

Market Research

Examining the future of the global pharma industry as two of the world’s biggest superpowers come to blows.

Key Points:

According to a new Pew Research Center survey in Q12021, 9 of 10 US adults (89%) considered China a competitor or enemy rather than a partner during the pandemic.
Still, in 2020, Chinese FDI in the US stood at the third position in pharma med-devices at $625 million despite the scrutiny tied to FIRRMA (Foreign Investment Risk Review Modernization Act).
This perception-based negativity will not impact the market. “Go China and No China” will soon be replaced by “No clarity over China.”

To know more...

Authors

Dr. Siddhartha Dutta

Dr. Sidhartha Dutta is a business technologist...

Related Topics

Whitepapers

The Evolving Landscape of Lead Generation

In today’s competitive business landscape, generating high-quality leads is a cornerstone of sustainable growth. Leads are potential customers who...

Whitepapers

ATxSG BroadcastAsia 2024: Key Trends

ATxSG is one of the leading technology conferences in Asia-Pacific with two primary focus avenues, i.e., BroadcastAsia and CommunicAsia, with close to...

Whitepapers

NAB 2024 Key Trends

SG Analytics (SGA)’s media and broadcast research & consulting team surveyed 13 vendors attending the 2024 NAB Show in Las Vegas in April 2024....

VIEW MORE

Much Ado About Nothing

Key Points:

Dr. Siddhartha Dutta

Related Topics

We bring comprehensive data driven insights to everyone, everywhere